Logan Capital Management Inc Bristol Myers Squibb CO Transaction History

Logan Capital Management Inc

$2.24 Billion
Q2 2024

A detailed history of Logan Capital Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Logan Capital Management Inc holds 39,786 shares of BMY stock, worth $2.12 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

39,786

Previous 45,168 11.92%

Holding current value

$2.12 Million

Previous $2.45 Million 32.54%

% of portfolio

0.07%

Previous 0.11%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $216,625 - $285,192	-5,382 Reduced 11.92%	39,786 $1.65 Million
Q1 2024 May 13, 2024	SELL	$47.98 - $54.4 $31,666 - $35,904	-660 Reduced 1.44%	45,168 $2.45 Million
Q4 2023 Feb 14, 2024	BUY	$48.48 - $57.85 $387 - $462	8 Added 0.02%	45,828 $2.35 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $7,699 - $8,609	133 Added 0.29%	45,820 $2.66 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $28,096 - $31,196	-441 Reduced 0.96%	45,687 $2.92 Million
Q1 2023 May 12, 2023	SELL	$65.71 - $74.53 $318,496 - $361,246	-4,847 Reduced 9.51%	46,128 $3.2 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $902,087 - $1.07 Million	13,173 Added 34.85%	50,975 $3.67 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $71 - $42,031	547 Added 1.47%	37,802 $2.69 Million
Q2 2022 Aug 11, 2022	SELL	$72.62 - $79.98 $44,225 - $48,707	-609 Reduced 1.61%	37,255 $2.87 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $3,012 - $3,612	-49 Reduced 0.13%	37,864 $2.77 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $35,127 - $40,950	-655 Reduced 1.7%	37,913 $2.36 Million
Q3 2021 Nov 12, 2021	BUY	$59.17 - $69.31 $177 - $207	3 Added 0.01%	38,568 $2.28 Million
Q2 2021 Aug 17, 2021	BUY	$61.91 - $67.42 $26,002 - $28,316	420 Added 1.1%	38,565 $2.58 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $237 - $266	4 Added 0.01%	38,145 $2.41 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $19,400 - $21,984	-336 Reduced 0.87%	38,141 $2.37 Million
Q3 2020 Nov 13, 2020	BUY	$57.43 - $63.64 $28,715 - $31,820	500 Added 1.32%	38,477 $2.32 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $25,765 - $30,122	-470 Reduced 1.22%	37,977 $2.23 Million
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $23,153 - $33,647	-499 Reduced 1.28%	38,447 $2.14 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $1.47 Million - $1.92 Million	29,872 Added 329.2%	38,946 $2.5 Million
Q2 2019 Jul 24, 2019	SELL	$44.62 - $49.34 $2,320 - $2,565	-52 Reduced 0.57%	9,074 $412,000
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $3,068 - $3,658	-68 Reduced 0.74%	9,126 $435,000
Q4 2017 Feb 12, 2018	BUY	$59.94 - $65.35 $3,116 - $3,398	52 Added 0.57%	9,194 $563,000
Q2 2017 Aug 14, 2017	BUY	N/A	9,142	9,142 $509,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Logan Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Logan Capital Management Inc with notifications on news.

Account

Logan Capital Management Inc Bristol Myers Squibb CO Transaction History